91 related articles for article (PubMed ID: 8074476)
1. Antiproliferative effect of genistein and adriamycin against estrogen-dependent and -independent human breast carcinoma cell lines.
Monti E; Sinha BK
Anticancer Res; 1994; 14(3A):1221-6. PubMed ID: 8074476
[TBL] [Abstract][Full Text] [Related]
2. Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells.
Peterson G; Barnes S
Cell Growth Differ; 1996 Oct; 7(10):1345-51. PubMed ID: 8891338
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor, growth factor receptor and protooncogene protein activities and possible signal transduction crosstalk in estrogen dependent and independent breast cancer cell lines.
Mohamood AS; Gyles P; Balan KV; Hollis VW; Eckberg WR; Asseffa A; Han Z; Wyche JH; Anderson WA
J Submicrosc Cytol Pathol; 1997 Jan; 29(1):1-17. PubMed ID: 9066137
[TBL] [Abstract][Full Text] [Related]
4. Curcumin and genistein, plant natural products, show synergistic inhibitory effects on the growth of human breast cancer MCF-7 cells induced by estrogenic pesticides.
Verma SP; Salamone E; Goldin B
Biochem Biophys Res Commun; 1997 Apr; 233(3):692-6. PubMed ID: 9168916
[TBL] [Abstract][Full Text] [Related]
5. [The inhibiting effect of genistein on the growth of human breast cancer cells in vitro].
He FJ; Wang J; Niu JZ; Wang JF
Zhongguo Zhong Yao Za Zhi; 2002 Dec; 27(12):936-9. PubMed ID: 12776537
[TBL] [Abstract][Full Text] [Related]
6. Potent inhibition of breast cancer cell lines by the isoflavonoid kievitone: comparison with genistein.
Hoffman R
Biochem Biophys Res Commun; 1995 Jun; 211(2):600-6. PubMed ID: 7794275
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of chemosensitivity and programmed cell death by tyrosine kinase inhibitors correlates with EGFR expression in non-small cell lung cancer cells.
Lei W; Mayotte JE; Levitt ML
Anticancer Res; 1999; 19(1A):221-8. PubMed ID: 10226546
[TBL] [Abstract][Full Text] [Related]
8. Effects of genistein and synergistic action in combination with eicosapentaenoic acid on the growth of breast cancer cell lines.
Nakagawa H; Yamamoto D; Kiyozuka Y; Tsuta K; Uemura Y; Hioki K; Tsutsui Y; Tsubura A
J Cancer Res Clin Oncol; 2000 Aug; 126(8):448-54. PubMed ID: 10961387
[TBL] [Abstract][Full Text] [Related]
9. [Status of estrogen receptor affects the drug sensitivity of drug-resistant MCF-7/Adr human breast cancer cells to droloxifene and Adriamycin].
Gao HD; Sun JZ; Bi DS; Ma R
Ai Zheng; 2003 Apr; 22(4):376-9. PubMed ID: 12703992
[TBL] [Abstract][Full Text] [Related]
10. Effect of tyrosine kinase inhibition on basal and epidermal growth factor-stimulated human Caco-2 enterocyte sheet migration and proliferation.
Basson MD; Beidler DR; Turowski G; Zarif A; Modlin IM; Jena BP; Madri JA
J Cell Physiol; 1994 Sep; 160(3):491-501. PubMed ID: 8077287
[TBL] [Abstract][Full Text] [Related]
11. Increased epidermal growth factor receptor in an estrogen-responsive, adriamycin-resistant MCF-7 cell line.
Dickstein B; Valverius EM; Wosikowski K; Saceda M; Pearson JW; Martin MB; Bates SE
J Cell Physiol; 1993 Oct; 157(1):110-8. PubMed ID: 8408230
[TBL] [Abstract][Full Text] [Related]
12. Interferon-enhancement of tyrosine phosphorylation of epidermal growth factor receptors in human breast carcinoma cells.
Huslig RL; Mishra S; Hamburger AW
Anticancer Res; 1993; 13(3):613-7. PubMed ID: 8317888
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic activity of epidermal growth factor-genistein against breast cancer cells.
Uckun FM; Narla RK; Jun X; Zeren T; Venkatachalam T; Waddick KG; Rostostev A; Myers DE
Clin Cancer Res; 1998 Apr; 4(4):901-12. PubMed ID: 9563884
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative effect of tyrosine kinase inhibitors in epidermal growth factor-stimulated growth of human gastric cancer cells.
Piontek M; Hengels KJ; Porschen R; Strohmeyer G
Anticancer Res; 1993; 13(6A):2119-23. PubMed ID: 8297123
[TBL] [Abstract][Full Text] [Related]
15. Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells.
Tyagi AK; Agarwal C; Chan DC; Agarwal R
Oncol Rep; 2004 Feb; 11(2):493-9. PubMed ID: 14719089
[TBL] [Abstract][Full Text] [Related]
16. FGF signaling activates STAT1 and p21 and inhibits the estrogen response and proliferation of MCF-7 cells.
Johnson MR; Valentine C; Basilico C; Mansukhani A
Oncogene; 1998 May; 16(20):2647-56. PubMed ID: 9632141
[TBL] [Abstract][Full Text] [Related]
17. Genistein inhibits proliferation similarly in estrogen receptor-positive and negative human breast carcinoma cell lines characterized by P21WAF1/CIP1 induction, G2/M arrest, and apoptosis.
Shao ZM; Alpaugh ML; Fontana JA; Barsky SH
J Cell Biochem; 1998 Apr; 69(1):44-54. PubMed ID: 9513045
[TBL] [Abstract][Full Text] [Related]
18. [Effect of medroxyprogesterone acetate on the anticellular activity of 5-fluorouracil against human breast and stomach cancer cells].
Ishida H; Okabe M; Gomi K; Horiuchi R
Gan To Kagaku Ryoho; 1993 Apr; 20(5):625-30. PubMed ID: 8470920
[TBL] [Abstract][Full Text] [Related]
19. [Toremifene sensitized the effect of adriamycin on human breast cancer cell lines].
Nakagomi H; Furuya K; Hagiwara J; Nishio T; Watanabe K; Muto S; Takano K; Tada Y
Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():454-8. PubMed ID: 9589052
[TBL] [Abstract][Full Text] [Related]
20. Genistein and daidzein induce cell proliferation and their metabolites cause oxidative DNA damage in relation to isoflavone-induced cancer of estrogen-sensitive organs.
Murata M; Midorikawa K; Koh M; Umezawa K; Kawanishi S
Biochemistry; 2004 Mar; 43(9):2569-77. PubMed ID: 14992594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
